Adamis AP - Search Results

1

Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Adamis AP, Berman AJ. Adamis AP, et al. Semin Immunopathol. 2008 Apr;30(2):65-84. doi: 10.1007/s00281-008-0111-x. Epub 2008 Mar 14. Semin Immunopathol. 2008. PMID: 18340447 Review.

2

A central role for inflammation in the pathogenesis of diabetic retinopathy.

Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP. Joussen AM, et al. Among authors: adamis ap. FASEB J. 2004 Sep;18(12):1450-2. doi: 10.1096/fj.03-1476fje. Epub 2004 Jul 1. FASEB J. 2004. PMID: 15231732

3

The rationale for drug combinations in age-related macular degeneration.

Adamis AP. Adamis AP. Retina. 2009 Jun;29(6 Suppl):S42-4. doi: 10.1097/IAE.0b013e3181ad2500. Retina. 2009. PMID: 19553800

4

Vascular endothelial growth factor gene regulation and action in diabetic retinopathy.

Lu M, Adamis AP. Lu M, et al. Among authors: adamis ap. Ophthalmol Clin North Am. 2002 Mar;15(1):69-79. doi: 10.1016/s0896-1549(01)00010-4. Ophthalmol Clin North Am. 2002. PMID: 12064083 Review.

5

Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathy.

Starita C, Patel M, Katz B, Adamis AP. Starita C, et al. Among authors: adamis ap. Dev Ophthalmol. 2007;39:122-148. doi: 10.1159/000098504. Dev Ophthalmol. 2007. PMID: 17245083 Review.

6

Suppression of diabetic retinopathy with angiopoietin-1.

Joussen AM, Poulaki V, Tsujikawa A, Qin W, Qaum T, Xu Q, Moromizato Y, Bursell SE, Wiegand SJ, Rudge J, Ioffe E, Yancopoulos GD, Adamis AP. Joussen AM, et al. Among authors: adamis ap. Am J Pathol. 2002 May;160(5):1683-93. doi: 10.1016/S0002-9440(10)61115-7. Am J Pathol. 2002. PMID: 12000720 Free PMC article.

7

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.

Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR, Adamis AP. Ng EW, et al. Among authors: adamis ap. Nat Rev Drug Discov. 2006 Feb;5(2):123-32. doi: 10.1038/nrd1955. Nat Rev Drug Discov. 2006. PMID: 16518379 Review.

8

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.

Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Döhmen S, Adamis AP. Joussen AM, et al. Among authors: adamis ap. FASEB J. 2002 Mar;16(3):438-40. doi: 10.1096/fj.01-0707fje. Epub 2002 Jan 30. FASEB J. 2002. PMID: 11821258

9

Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration.

Ng EW, Adamis AP. Ng EW, et al. Among authors: adamis ap. Can J Ophthalmol. 2005 Jun;40(3):352-68. doi: 10.1016/S0008-4182(05)80078-X. Can J Ophthalmol. 2005. PMID: 15947805 Review.

10

Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases.

Ng EW, Adamis AP. Ng EW, et al. Among authors: adamis ap. Ann N Y Acad Sci. 2006 Oct;1082:151-71. doi: 10.1196/annals.1348.062. Ann N Y Acad Sci. 2006. PMID: 17145936 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters